Lupus Foundation of America2d
First Person Dosed with Investigational Therapy, ADI-001, for Treatment of Lupus Nephritis
Adicet Bio announced the first person with lupus nephritis (LN) has been dosed with ADI-001, an investigational allogeneic gamma delta CAR T cell therapy that targets B cells. The phase 1 study of ADI ...
Lupus Foundation of America4d
Lupus Research Highlights From American College of Rheumatology’s 2024 Scientific Meeting
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...
Lupus Foundation of America5d
ACR 2024 - New Guideline for the Screening, Treatment and Management of Lupus Nephritis
There are multiple chapters near you. Select your preferred chapter.
Lupus Foundation of America11d
Leaders in Lupus Research Receive Prestigious Awards from Lupus Foundation of America for Significant Contributions to the Field
The Lupus Foundation of America (LFA) is proud to honor two exceptional lupus researchers at the 2024 Evelyn V. Hess ...
Lupus Foundation of America11d
UPDATE: Seattle Children’s Now Enrolling Participants for First U.S. CAR T Cell Clinical Trial for Children with Systemic Lupus Erythematosus
Seattle Children’s announced they are now enrolling participants in the first CAR T cell clinical trial for children with ...
Lupus Foundation of America11d
Researchers Identify Potential New Gene Biomarker for Diagnosis and Evaluation of People with Systemic Lupus Erythematosus
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to ...
Lupus Foundation of America11d
Study Examines Various Therapeutic Options for Lupus Nephritis and their Effectiveness
A range of medications are available to help treat lupus nephritis (LN), each offering a specific role in managing the ...
Lupus Foundation of America9d
Lupus Foundation of America Latest Research Achievements to be Featured at the 2024 American College of Rheumatology Annual Meeting
The Lupus Foundation of America (LFA), along with numerous researchers funded by the Foundation, will present novel lupus discoveries as part of the American College of Rheumatology Convergence 2024 ...